InnovAge Appoints Dr. Paul Taheri as Chief Medical Officer
InnovAge (Nasdaq: INNV) appointed Paul Taheri, MD, MBA as Chief Medical Officer, effective November 3, 2025. Dr. Taheri is a board-certified trauma surgeon with more than 30 years of healthcare leadership, including roles as CEO and Deputy Dean for Clinical Affairs at Yale School of Medicine and CEO of the University of Vermont Medical Group. He has served as a Clinical Quality Advisor since 2019 and holds an MBA from the University of Michigan.
InnovAge serves approximately 7,740 participants across 20 centers in six states as of June 30, 2025; the appointment is framed as strengthening clinical leadership for the company’s PACE model.
InnovAge (Nasdaq: INNV) ha nominato Paul Taheri, MD, MBA come Chief Medical Officer, con effetto 3 novembre 2025. Il Dott. Taheri è un chirurgo trauma certificato e ha oltre 30 anni di leadership sanitaria, inclusi ruoli di CEO e Vice-Decano per gli Affari Clinici presso la Yale School of Medicine e CEO della University of Vermont Medical Group. Ha servito come Consulente di Qualità Clinica dal 2019 e possiede un MBA dall'Università del Michigan.
InnovAge serve circa 7.740 partecipanti in 20 centri in sei stati al 30 giugno 2025; la nomina è inquadrata come un rafforzamento della leadership clinica per il modello PACE dell'azienda.
InnovAge (Nasdaq: INNV) designó a Paul Taheri, MD, MBA como Director Médico (Chief Medical Officer), con efecto a partir del 3 de noviembre de 2025. El Dr. Taheri es un cirujano de trauma certificado con más de 30 años de liderazgo en atención médica, incluyendo roles como CEO y Subdecano de Asuntos Clínicos en la Yale School of Medicine y CEO de University of Vermont Medical Group. Ha trabajado como Asesor de Calidad Clínica desde 2019 y posee un MBA de la Universidad de Michigan.
InnovAge atiende aproximadamente a 7.740 participantes en 20 centros en seis estados a 30 de junio de 2025; el nombramiento se presenta como un fortalecimiento del liderazgo clínico para el modelo PACE de la empresa.
InnovAge (나스닥: INNV)는 Paul Taheri, MD, MBA를 최고의료책임자(Chief Medical Officer)로 임명했고, 발효일은 2025년 11월 3일입니다. Taheri 박사는 30년이 넘는 보건의료 리더십 경력을 가진 보건의료 외상외과 전문의이며 Yale 의과대학의 임상업무부학장 겸 CEO, 버몬트 대학교 의과그룹의 CEO를 역임했습니다. 2019년부터 임상품질고문으로 활동했고 미시간 대학교에서 MBA를 취득했습니다.
InnovAge는 2025년 6월 30일 기준으로 20개 센터에서 약 7,740명의 참가자를 서비스하고 있으며; 이 임명은 회사의 PACE 모델에 대한 임상 리더십 강화를 위한 것으로 해석됩니다.
InnovAge (Nasdaq : INNV) a nommé Paul Taheri, MD, MBA au poste de Directeur Médical (Chief Medical Officer), à compter du 3 novembre 2025. Le Dr Taheri est un chirurgien traumatique certifié avec plus de 30 ans d'expérience en leadership en soins de santé, notamment en tant que PDG et Doyen Adjoint des Affaires Cliniques à la Yale School of Medicine et PDG du University of Vermont Medical Group. Il a été Conseiller en Qualité Clinique depuis 2019 et est titulaire d'un MBA de l'Université du Michigan.
InnovAge sert environ 7 740 participants dans 20 centres dans six états au 30 juin 2025; la nomination est présentée comme le renforcement du leadership clinique pour le modèle PACE de l'entreprise.
InnovAge (Nasdaq: INNV) hat Paul Taheri, MD, MBA zum Chief Medical Officer ernannt, wirksam ab dem 3. November 2025. Dr. Taheri ist ein zertifizierter Traumaschirurg mit mehr als 30 Jahren Führungserfahrung im Gesundheitswesen, darunter Rollen als CEO und Deputy Dean for Clinical Affairs an der Yale School of Medicine sowie CEO der University of Vermont Medical Group. Er dient seit 2019 als Clinical Quality Advisor und besitzt einen MBA der University of Michigan.
InnovAge betreut ungefähr 7.740 Teilnehmer in 20 Zentren in sechs Bundesstaaten zum 30. Juni 2025; die Berufung wird als Stärkung der klinischen Führung für das PACE-Modell des Unternehmens gesehen.
InnovAge (بورصة ناسداك: INNV) عينت Paul Taheri, MD, MBA كطبيب رئيسي للأطباء (Chief Medical Officer)، اعتباراً من 3 نوفمبر 2025. الدكتور Taheri جراح صدمات معتمد ولديه أكثر من 30 عاماً من القيادة في الرعاية الصحية، بما في ذلك مناصب كمدير تنفيذي ونائب عميد الشؤون الإكلينيكية في كلية الطب بجامعة Yale وCEO لمجموعة جامعة فيرمونت الطبية. لقد خدم كمستشار جودة سريرية منذ 2019 ويحمل MBA من جامعة ميشيغان.
تخدم InnovAge حوالي 7,740 مشاركاً عبر 20 مركزاً في ست ولايات حتى 30 يونيو 2025؛ تُعد التعيين خطوة نحو تعزيز القيادة السريرية لنموذج PACE للشركة.
- Appointment effective November 3, 2025
- 30+ years of clinical and executive healthcare experience
- InnovAge served ~7,740 participants as of June 30, 2025
- None.
DENVER, Nov. 03, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), appoints Paul Taheri, MD, MBA as its Chief Medical Officer, effective November 3, 2025.
Dr. Paul Taheri, a board-certified trauma surgeon, brings more than 30 years of healthcare leadership to InnovAge. He has served as a Clinical Quality Advisor to Welsh, Carson, Anderson & Stowe, a role he has held since 2019. Dr. Taheri previously served as CEO and Deputy Dean for Clinical Affairs at the Yale School of Medicine. His earlier leadership roles include President and CEO of the University of Vermont Medical Group, Senior Associate Dean for Clinical Affairs, and professor of surgery. He also held key positions at the University of Michigan in Ann Arbor, where he earned his MBA from the Ross School of Business. Dr. Taheri received his medical degree from New York University and completed his surgical residency at Tulane University.
“Paul brings a rare combination of clinical excellence, operational discipline, and strategic leadership to InnovAge,” said Patrick Blair, CEO. “With more than 3 decades of healthcare experience and his knowledge as a provider, we welcome him to InnovAge and are excited about the experience and stead leadership we expect him to bring to our clinical teams and the participants we serve every day.”
About InnovAge
InnovAge is a market leader in managing the care of high-cost, dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). With a mission of enabling older adults to age independently in their own homes for as long as safely possible, InnovAge’s patient-centered care model is designed to improve the quality of care its participants receive while reducing over-utilization of high-cost care settings. InnovAge believes its PACE healthcare model is one in which all constituencies — participants, their families, providers, and government payors — “win.” As of June 30, 2025, InnovAge served approximately 7,740 participants across 20 centers in six states. https://www.innovage.com/.
Investor Contact:
Ryan Kubota
RKubota@InnovAge.com
Media Contact:
Lara Hazenfield
Lhazenfied@InnovAge.com
This press release was published by a CLEAR® Verified individual.
FAQ
Who is InnovAge’s new Chief Medical Officer and when did the appointment take effect for INNV?
What clinical and leadership experience does InnovAge CMO Paul Taheri have?
How many participants does InnovAge (INNV) serve and in how many centers as of mid-2025?
What education does InnovAge’s new CMO hold and where did he earn his MBA?
What role did Paul Taheri hold with Welsh, Carson, Anderson & Stowe before joining InnovAge?
What does the CMO appointment mean for InnovAge’s PACE model and participants (INNV)?
